ArriVent BioPharma, Inc. 10-Q filing
Filed 2025-08-11 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001558370-25-010975
- Form type
- 10-Q
- CIK
- 0001868279
- Primary document
- https://www.sec.gov/Archives/edgar/data/1868279/000155837025010975/avbp-20250630x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ArriVent BioPharma, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-100.4M | - | - |
| Net Income | $-95.8M | - | - |
| Eps Basic | -2.78 | - | - |
| Eps Diluted | -2.78 | - | - |
| Cash And Equivalents | $112.8M | - | - |
| Total Assets | $269.5M | - | - |
| Total Liabilities | $19.6M | - | - |
| Shareholders Equity | $249.9M | - | - |
| Operating Cash Flow | $-94.1M | - | - |